Profile
SPRO NVO VRTX REGN SGEN MRNA
Company Name Spero Therapeutics, Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Moderna, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $79.19M $556.82B $101.64B $96.50B $43.15B $39.05B
Employees 0.05K 63.37K 5.40K 13.45K 3.26K 5.60K
CEO Mr. Satyavrat Shukla C.F.A. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Stephane Bancel
Ratings
SPRO NVO VRTX REGN SGEN MRNA
Quant Rating Score 4 5 5 5 3 4
Quant Rating Buy Strong Buy Strong Buy Strong Buy Neutral Buy
Trading
SPRO NVO VRTX REGN SGEN MRNA
Last Close $1.47 $122.75 $393.48 $893.99 $228.74 $102
High 52 $1.95 $199.54 $446.08 $993.35 $228.9 $142.82
Low 52 $1 $87.78 $323.3 $692.45 $187.64 $69.51
Price vs. 52 Week High -24.62 % -38.48 % -11.79 % -10 % -0.07 % -28.58 %
Price vs. 52 Week Low 47 % 39.84 % 21.71 % 29.11 % 21.9 % 46.74 %
Total Return
SPRO NVO VRTX REGN SGEN MRNA
1 Month Return -17.42 % -6.56 % -5.23 % -7.23 % 0 % -2.96 %
3 Month Return 5.76 % 14.74 % -9.55 % -4.22 % 0 % 2.31 %
6 Month Return 34.25 % 25.69 % 7.86 % 10.55 % 6.41 % 23.83 %
9 Month Return -0.68 % -23.39 % 9.74 % 24.34 % 17 % -18.51 %
YTD Return 0 % 18.66 % -3.3 % 1.79 % 0 % 2.56 %
1 Year Return -16 % -25.62 % 19.8 % 10.52 % 11.58 % -28.58 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SPRO NVO VRTX REGN SGEN MRNA
Dividend Yield Percentage (TTM) - 1.48 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) - 1.54 % 10.64 % 5.88 % -3.35 % -3.75 %
Dividend Per Share (TTM) - 1.81 % - - - -
Payout Ratio (TTM) - 37.96 % 2.04 % - - -2.63 %
Growth
SPRO NVO VRTX REGN SGEN MRNA
Asset Growth 46.14 % 30.35 % 25.23 % 13.23 % -1.21 % -28.74 %
Gross Profit Growth 104.9 % 32.32 % 9.25 % 6.49 % 22.93 % -85.12 %
Revenue Growth 99.13 % 31.26 % 10.17 % 7.76 % 24.65 % -64.94 %
Revenue 3 Year 340.39 % 90.51 % 59.87 % 56.27 % 91.84 % 2354.12 %
Revenue 5 Year 640.56 % 124.2 % 218.58 % 97.36 % 215.48 % 1070.62 %
Revenue 10 Year - 66.11 % 608.27 % 509.63 % 494.04 % 6447.35 %
EBIT Growth 146.78 % 37.11 % -12.94 % -14.6 % 10.13 % -145 %
Net Income Growth 147.48 % 50.71 % 8.96 % -8.87 % 9.51 % -156.37 %
Net Income 3 Yeari Growth Per Share 112.5 % 106.79 % 34.59 % 13.92 % -764.83 % -529.35 %
Net Income 5 Yeari Growth Per Share 116.62 % 133.86 % 70.33 % 63.31 % -276.93 % -160.17 %
Net Income 10 Yeari Growth Per Share 128.15 % 98.61 % 809.6 % 811.34 % -624.16 % -2046.03 %
Operating Income Growth 146.78 % 37.11 % -12.94 % -14.6 % 10.13 % -145 %
Operating Cash Flow Growth (CFG) -326.79 % 38.06 % -14.35 % -8.39 % 9.07 % -162.6 %
Operating 3 Year CFG 83.68 % 118.29 % 9.63 % 77.63 % -148.34 % -253.42 %
Operating 5 Year CFG 74.72 % 163.51 % 174.78 % 111.31 % -195.86 % -100.11 %
Operating 10 Year CFG 56.96 % 150.92 % 5187.08 % 663.48 % -2622.09 % -4698.89 %
EPS Growth 133.59 % 52.28 % 8.33 % -8.54 % 10.81 % -158.04 %
EPS Diluted Growth 133.59 % 52.37 % 8.35 % -9.03 % 10.81 % -161.33 %
Book Value Per Share 0.39 % 29 % 25.58 % 14.4 % -9.83 % -21.18 %
Share Holder 3 Year Equity Growth Per Share -65.61 % 75.22 % 104.06 % 138.48 % 33.92 % 439.47 %
Share Holder 5 Year Equity Growth Per Share -71.99 % 121.9 % 291.14 % 199.46 % 220.81 % 92.24 %
Share Holder 10 Year Equity Growth Per Share 6734.69 % 49.62 % 1030.79 % 1201.51 % 691.19 % 1519.81 %
Dividend Per Share Growth -100 % 26.89 % - - - 59.65 %
Dividend 3 Year Growth Per Share - 64.4 % -100 % - - 3725.19 %
Dividend 5 Year Growth Per Share - 80.03 % -100 % - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth -16.61 % 4.74 % 44.1 % 0.06 % -23.28 % 3.58 %
Free Cash Flow Growth -326.79 % 9.17 % -16.47 % -17.11 % 3.67 % -183.5 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
SPRO NVO VRTX REGN SGEN MRNA
Gross Profit Margin TTM 81.14 % 84.6 % 87.21 % 87.87 % 75.4 % 31.49 %
Return on Assets TTM 13.03 % 26.61 % 15.92 % 11.95 % -20.64 % -25.58 %
Return on Equity TTM 33.93 % 90.49 % 22.62 % 16.07 % -28.06 % -29.87 %
Return on Capital Employed TTM 13.62 % 70.82 % 19.82 % 13.65 % -29.5 % -27.51 %
Net Income Per EBT TTM 93.55 % 79.95 % 82.64 % 94.15 % 101.53 % 119.58 %
EBT Per Ebit TTM 128.41 % 102.05 % 115.19 % 103.76 % 93.47 % 92.99 %
EBIT Per Revenue TTM 20.02 % 44.16 % 38.53 % 30.85 % -34.37 % -61.88 %
Cash Flow To Debt Ratio TTM -595.26 % 403.27 % 437.57 % 169.97 % -475.96 % -250.84 %
Receivables Turnover TTM 1.95 3.09 6.31 2.31 3.64 6.34
Payables Turnover TTM 13.52 1.4 3.46 2.62 2.52 9.03
Inventory Turnover TTM - 1.12 1.71 0.62 1.07 23.23
Fixed Asset Turnover TTM 2377.39 % 255.34 % 679.28 % 316.35 % 471.71 % 257.71 %
Asset Turnover TTM 54.18 % 73.85 % 43.42 % 39.65 % 63.3 % 37.18 %
Operating Cash Flow Per Share TTM -0.62 24.39 13.73 43.1 -2.87 -8.18
Free Cash Flow Per Share TTM -0.62 15.68 12.72 35.77 -3.73 -10.04
Cash Per Share TTM 144.03 % 677.09 % 4354.48 % 10173.36 % 657.5 % 2258.27 %
Operating Cash Flow Sales Ratio TTM -33.39 % 46.89 % 35.84 % 35.02 % -23.48 % -45.52 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 64.29 % 92.69 % 83.01 % 129.82 % 122.67 %
Cash Flow Coverage Ratios TTM -595.26 % 403.27 % 437.57 % 169.97 % -475.96 % -250.84 %
Price To Free Cash Flows Ratio TTM -2.4 55.72 31 25.31 -61.54 -10.21
Price To Operating Cash Flows Ratio TTM -2.36 35.25 28.67 20.74 -79.67 -12.46
Price Cash Flow Ratio TTM -2.36 35.25 28.67 20.74 -79.67 -12.46
Income Statement (TTM)
SPRO NVO VRTX REGN SGEN MRNA
Revenue $0.1B $232.26B $9.84B $13.12B $1.96B $6.75B
Gross Profit $0.1B $196.5B $8.58B $11.3B $1.55B $2.06B
Gross Profit Ratio 99.62% 84.6% 87.17% 86.16% 79.1% 30.52%
EBITDA $0.02B $112.94B $3.93B $5.13B $-0.62B $-3.21B
Net Income $0.02B $83.68B $3.62B $3.95B $-0.61B $-4.71B
EPS Diluted 0.43 18.62 13.89 34.77 -3.3 -12.34
Balance Sheet (MRQ)
SPRO NVO VRTX REGN SGEN MRNA
Long Term Debt $0B $20.53B $0.72B $2.7B $0.04B $1.22B
Total Liabilities $0.08B $207.93B $5.15B $7.11B $0.87B $4.57B
Total Equity $0.11B $106.56B $17.58B $25.97B $2.8B $13.85B
Total Investments $0.05B $17.5B $3.45B $13.51B $1.42B $4.68B
Total Debt $0.01B $27.01B $0.81B $2.7B $0.04B $1.24B
Total Assets $0.18B $314.49B $22.73B $33.08B $3.67B $18.43B
Cash Flow Statement (TTM)
SPRO NVO VRTX REGN SGEN MRNA
Net Income $0.02B $83.68B $3.62B $3.95B $-0.61B $-4.71B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $0.75B
Dividends Paid $0B $-31.77B $0B $0B $0B $-0.27B
Operating Cash Flow $-0.03B $108.91B $3.54B $4.59B $-0.45B $-3.12B
Capital Expenditure $0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.71B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.84
ABCL AbCellera Biologics Inc. 3.87
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 7.6
ABIO ARCA biopharma, Inc. 3.38
ABOS Acumen Pharmaceuticals, Inc. 3.145
ABSI Absci Corporation 4.75
ABUS Arbutus Biopharma Corporation 2.73
ABVC ABVC BioPharma, Inc. 0.9999
ABVX Abivax SA American Depositary Shares 15.31
ACAD ACADIA Pharmaceuticals Inc. 16.83
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 1.95
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.7846
ACHV Achieve Life Sciences, Inc. 4.54
ACIU AC Immune SA 2.36
ACLX Arcellx, Inc. 51.68
ACRV Acrivon Therapeutics, Inc. Common Stock 9.38
ACST Acasti Pharma Inc. 2.89
ETFs With Exposure to SPRO
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 245.27
IBB iShares Biotechnology ETF 0.01 124.68
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00011 108.81
VHT Vanguard Health Care Index Fund 0 253.31
BIB ProShares Ultra Nasdaq Biotechnology 0 48.13
VXF Vanguard Extended Market Index Fund 0 161.69
IWC iShares Micro-Cap ETF 0.01562 110.085
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 85.7
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 85.66
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 44.84
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 44.83
VBINX Vanguard Balanced Index Fund Investor Shares 0 44.84
DFAU Dimensional US Core Equity Market ETF 0 34.51
IBBQ Invesco Nasdaq Biotechnology ETF 0.01 20.14
DFAS Dimensional U.S. Small Cap ETF 0.00004316 57.93
VTSAX Vanguard Total Stock Market Index Fund 0 120.3
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01 5.8625
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 122.81
VITSX Vanguard Total Stock Market Index Fund 0 120.32
QQQS Invesco NASDAQ Future Gen 200 ETF 0.538 23.779
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000210531 84.66
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 122.82
VEXPX Vanguard Explorer Fd 0 110.18
VHCIX Vanguard HealthCare Index Fund Admiral Shs 0 126.47
JKK iShares Morningstar Small-Cap Growth ETF 0.02 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
DFQTX DFA U.S. Core Equity 2 Portfolio 0 33.68
VEMPX Vanguard Extended Market Index InstlPlus 0 303.08
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 225.68
Unlock